Revmatoide

Revmatoide is a term often used in some languages, notably in Portuguese, to refer to rheumatoid arthritis, a chronic autoimmune disorder that primarily affects joints. It is characterized by inflammation of the synovial membranes, leading to joint pain, swelling, stiffness, and potential loss of function.

The condition can affect individuals of all ages but is most commonly diagnosed in middle-aged individuals. Rheumatoid arthritis is considered an autoimmune disease because the immune system mistakenly attacks the body's own tissues, causing inflammation and joint damage. The exact cause of revmatoide remains unknown, but genetic, environmental, and hormonal factors are believed to play roles.

Symptoms typically include symmetrical joint pain, swelling, morning stiffness lasting more than 30 minutes, and fatigue. As the disease progresses, it may lead to joint deformities and erosion of bone and cartilage if left untreated. Systemic symptoms such as fever, weight loss, and general malaise can also occur.

Diagnosis is based on clinical evaluation, blood tests indicating inflammation (e.g., elevated ESR or CRP), rheumatoid factor (RF), anti-cyclic citrullinated peptide (anti-CCP) antibodies, and imaging studies like X-rays or ultrasound to assess joint damage.

Treatment aims to reduce inflammation, relieve symptoms, and prevent joint damage. Common approaches include disease-modifying antirheumatic drugs (DMARDs) such as methotrexate, biological agents like TNF inhibitors, and corticosteroids. Physical therapy and lifestyle modifications also play important roles in managing the disease.

Early diagnosis and treatment are crucial to improving long-term outcomes and quality of life for individuals with revmatoide.